dc.contributor.author | Parker, C | |
dc.contributor.author | Sydes, MR | |
dc.date.accessioned | 2017-08-21T13:13:04Z | |
dc.date.issued | 2018-02 | |
dc.identifier.citation | European urology, 2018, 73 (2), pp. 166 - 167 | |
dc.identifier.issn | 0302-2838 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/789 | |
dc.identifier.eissn | 1873-7560 | |
dc.identifier.doi | 10.1016/j.eururo.2017.07.025 | |
dc.format | Print-Electronic | |
dc.format.extent | 166 - 167 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.rights.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
dc.subject | Seminal Vesicles | |
dc.subject | Humans | |
dc.subject | Prostatic Neoplasms | |
dc.subject | Neoplasm Recurrence, Local | |
dc.subject | Prostate-Specific Antigen | |
dc.subject | Salvage Therapy | |
dc.subject | Prostatectomy | |
dc.subject | Male | |
dc.title | Salvage Treatment After Radical Prostatectomy. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2017-07-20 | |
rioxxterms.funder | The Institute of Cancer Research | |
rioxxterms.identifier.project | Unspecified | |
rioxxterms.versionofrecord | 10.1016/j.eururo.2017.07.025 | |
rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2018-02 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | European urology | |
pubs.issue | 2 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 73 | |
pubs.embargo.terms | Not known | |
dc.contributor.icrauthor | Parker, Chris | |
dc.contributor.icrauthor | Marsden, | |